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Abstract
Background: The cost-benefit of raccoon rabies control strategies such as oral rabies vaccination
(ORV) are under evaluation. As an initial quantification of the potential cost savings for a control
program, the collection of selected rabies cost data was pilot tested for five counties in New York
State (NYS) in a three-year period.
Methods: Rabies costs reported to NYS from the study counties were computerized and linked
to a human rabies exposure database. Consolidated costs by county and year were averaged and
compared.
Results: Reported rabies-associated costs for all rabies variants totalled $2.1 million, for human
rabies postexposure prophylaxes (PEP) (90.9%), animal specimen preparation/shipment to
laboratory (4.7%), and pet vaccination clinics (4.4%). The proportion that may be attributed to
raccoon rabies control was 37% ($784,529). Average costs associated with the raccoon variant
varied across counties from $440 to $1,885 per PEP, $14 to $44 per specimen, and $0.33 to $15
per pet vaccinated.
Conclusion: Rabies costs vary widely by county in New York State, and were associated with
human population size and methods used by counties to estimate costs. Rabies cost variability must
be considered in developing estimates of possible ORV-related cost savings. Costs of PEPs and
specimen preparation/shipments, as well as the costs of pet vaccination provided by this study may
be valuable for development of more realistic scenarios in economic modelling of ORV costs versus
benefits.
Background
Rabies, caused by infection with a lyssavirus, has a world-
wide distribution and has affected mankind since antiq-
uity. Rabies is almost 100% fatal following serious
neurological symptoms and great suffering [1]. Rabies has
a significant impact on health system costs, both for ani-
mal rabies control and for human postexposure treatment
[1]. Costs for rabies prevention have been estimated to be
$230 million to $1 billion per year in the U.S. [2]. The
recent increase in wildlife rabies, particularly in raccoons,
has contributed significantly to the economic impact of
rabies in the U.S., due to large increases in activities for
prevention and control [3,4].
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U.S. rabies variants
The epidemiology of rabies in the U.S. has changed from
a predominance in domestic animals to a predominance
in wild animals [4]. Bat rabies variants are widely distrib-
uted, whereas terrestrial rabies variants are more focally
distributed. Specific skunk variants are located in Califor-
nia, the northern Midwest, and the southern Midwest; fox
variants are located in west Texas and southern Arizona;
the dog/coyote variant is concentrated along the U.S./
Mexico border; and the raccoon variant is located in east-
ern states [5]. Raccoon rabies, first identified in Florida in
the 1940's, spread to the Mid-Atlantic States in the 1970's,
and the northeastern U.S. in the 1990's [6,7]. In 1999,
Canada reported its first epizootic of raccoon rabies [8].
In the eleven eastern states from North Carolina to New
York (NY), 82% of the counties reported the presence of
rabid raccoons during 1977–1997 [9]. Analyses of the
geographic/temporal distribution of cases indicate that
the raccoon rabies epizootic led to a subsequent epizootic
of raccoon-variant rabies in skunks. Epizootics in both
species moved in a similar direction from 1990 to 2000
[10]. Another study found that raccoon rabies spreads
with a velocity of approximately 46 kilometers (km) per
year [11]. The spread velocity of the raccoon epizootic for
NY was estimated at 48 km per year northward [12]. Envi-
ronmental barriers such as rivers slow the transmission as
much as seven-fold from township to township, but do
not stop it [11-13].
Human postexposure treatment
A major cost associated with rabies is human postexpo-
sure prophylaxis (PEP), sometimes referred to as postex-
posure treatment. In the U.S., PEP consists of five doses of
cell culture-derived rabies vaccine over the period of a
month plus a single dose of rabies immune globulin [14].
PEP is expensive with a cost range of $1,038–$4,447 [15].
In NY, the average was $1,136 [16]. Studies suggest PEP is
overused, which impacts overall costs [17,18]. Research-
ers estimated that PEP was unnecessary for about 40% of
patients, while treatment had been inappropriately with-
held in 6.3% of patients [19]. In areas currently free of rac-
coon rabies, PEP overuse is already a problem, and the
spread of raccoon rabies will likely further increase PEP
expenses [20]. When raccoon rabies reached Hunterdon
and Warren counties in New Jersey, PEP cost was $1,100
per 100,000 population (pre-epizootic period), and by
1990 the cost was $74,734 per 100,000 population (epiz-
ootic period) [21].
Animal vaccination
Primary prevention of rabies is based on animal vaccina-
tion [22], and many states require vaccination of pets
[23]. An innovative wildlife rabies vaccination approach
has used an oral rabies vaccine (ORV). ORV is used in 16
European countries, Israel, and North Africa for several
animal species, including dogs, foxes, raccoon dogs, badg-
ers, martens, wolves, and jackals [24-26]. In the U.S., a
vaccinia-rabies glycoprotein recombinant vaccine (V-RG)
is used. ORV is restricted to use in state or federally-
approved rabies control programs and projects [22]. Its
use is intended to reduce rabies-associated costs and pre-
vent further spread of raccoon rabies to previously unaf-
fected areas [23]. ORV has also been used for coyotes and
foxes in Texas [24]. In Ontario, Canada the use of ORV
between 1990 and 2000 reduced fox variant rabies cases
by 90%. During the same period, a reduction of 50% in
human PEPs was also documented [8].
Although the use of ORV in Canada and France has been
linked with reductions in rabid animals [8,27], the
administration of ORV programs is very expensive [28].
The benefits compared to costs can be high as in Europe
in which highly concerted, nationally coordinated actions
utilizing detailed knowledge of wildlife habitats and
demography led to elimination of terrestrial rabies in
Switzerland, Austria and large parts of Germany and
France. To determine the cost/benefit ratio in the U.S.,
additional studies are required to document the economic
impacts associated with raccoon variant rabies (which can
be quantified as a 'benefit' of ORV programs in terms of
costs avoided), determine the optimal bait density and
the optimal distribution of the ORV baits, and better
define the costs involved in an ORV program [28,29].
According to a recent study, preventing the westward
spread of raccoon rabies in the U.S. is economically bene-
ficial using ORV, even at an estimated cost between $58
million and $148 million for a 20-year control program
[30].
Rabies in NY
NY is representative of many states with multiple rabies
variants and a mixture of urban, suburban and rural areas
with a large human population potentially at risk for
exposure [16,31]. Raccoon variant rabies was first
detected in 1990 [12]. Initial studies indicate that raccoon
rabies has had a significant impact on the epidemiology of
rabies and associated health care costs. Raccoons repre-
sented 75% of the rabid animals from 1993–1998 [16].
Even prior to licensure of V-RG for use in raccoons, NY
began a pilot ORV program in 1994. Initial cost estimates
for a NY wildlife rabies control campaign including ORV
were $10.7 million per year, and $73 million for a 10-year
campaign [12]. The Department of Health (NYSDOH)
baited two counties between the Adirondack Mountains
and Lake Champlain to prevent northward rabies spread
to Canada [31]. In 1996 Cornell University, in collabora-
tion with the NYS Department of Environmental Conser-
vation (NYSDEC) and the Ontario Ministry of Natural
Resources, Canada, started an additional project to dis-
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tribute baits in three northwestern counties [32]. In recent
years, the United States Department of Agriculture's Wild-
life Services has played a major role in both the NYSDOH
and Cornell programs.
By law, NY places responsibility for rabies control and sur-
veillance on the 57 local health departments (LHDs) out-
side New York City (NYC). NYSDOH operates a unique
rabies reimbursement and reporting system for author-
ized PEPs (with third party medical insurance first applied
to the cost of treatment), collection, preparation and sub-
mission of animal specimens to the State's Rabies Labora-
tory for testing, and five annual no-cost rabies vaccination
clinics for dogs, cats and ferrets per county (recently
reduced to three per year).
LHDs submit quarterly vouchers detailing expenses for
these categories of rabies prevention activity. PEP
expenses are reimbursed if the case has been reported
using the NYSDOH reporting system, and are limited to a
maximum of $1,000 per patient. For animal specimens,
reimbursement requires reporting species, laboratory ID
number, date of shipment, and cost of preparation/ship-
ping, and is limited depending on species. Vaccination
clinic reimbursement is limited to $5000 per county per
year [33].
Study objective
Previous studies of NY rabies PEP and rabies costs did not
assess costs by variant [16,17] or variability by geographic
location. To address these issues, this study used detailed
voucher and reimbursement data and matched the
records to the rabies exposure database. Reimbursement
data was summarized by fiscal year rather than date of
reimbursement.
To pilot test the computerization and analysis of rabies-
control costs reported to NYSDOH, with emphasis on rac-
coon variant-associated costs to provide more specific cost
estimates for ORV cost-benefit modelling, five counties
were selected to represent diverse conditions of demo-
graphics, rabies epidemiology and reporting.
Methods
Data
This study includes reimbursement data from three con-
secutive fiscal years (April through March): 1999–2000,
2000–2001, and 2001–2002. Five counties were selected
for the analysis, to represent diverse areas: the lower Hud-
son valley, upper Hudson valley, western NYS, central
NYS, and northeastern NYS. One of the counties had an
ORV program. Four counties have full service LHDs,
including an environmental health program responsible
for rabies exposure investigations. One of the LHDs is
'partial service' and relies on public health nurses for
rabies follow-up. These counties represent 12.9% of the
NY population, and 23.5% of the population outside
NYC (Census 2000 data). With only one partial service
county, which also was the only county with ORV, the
association of cost data with being a partial service county
and being exposed to ORV was not examined in this pilot
study.
Vouchers were reviewed to identify PEPs begun during the
study fiscal years, and vaccination clinics and specimen
shipments during this same time period. A master list of
names was used to link computerized databases. After
data matching, cleaning, and extraction, names were
deleted retaining identification codes from original data
sources. Documents used for specimen preparation/ship-
ment cost calculations were private carrier bills (UPS/Air-
borne Express), veterinarian bills/vouchers and
information on personnel salaries.
Variables included expenses and dates for PEP treatments,
specimen preparation/shipment, and vaccination clinics;
amount paid by third party insurers for PEPs; amount of
donations collected for vaccination clinics; amount reim-
bursed to LHDs by the State; and species involved in inci-
dents or submitted for testing. When the amount of
donations collected for vaccination clinics exceeded costs,
the county cost was considered zero and the donation
excess was not accounted in the total clinic cost.
LHD telephone interviews were used to determine how
the LHDs calculated the specimen shipment costs and the
information sources used for the calculations; and to
understand the meaning of low values reported in the cost
of PEPs and specimen shipments.
Statistical analyses
To determine which control costs might be reduced or
eliminated due to a successful ORV program, animal spe-
cies involved in human rabies exposures were grouped
into bats and non-bats (i.e., terrestrial). Most of the
rodents were grouped together with the exception of
squirrels and woodchucks because there were rabies cases
in these species in recent years in the U.S. [34]. All terres-
trial species whose frequencies were lower than ten ani-
mals were grouped as "other." Analyses were performed
either excluding or including bats. Detailed analyses were
conducted for costs related to terrestrial rabies.
The NYSDOH Wadsworth Center's Rabies Laboratory
tests the variant for all rabid animals other than raccoons,
and for a periodic sample of raccoons. A 20 year assess-
ment identified variants other than raccoon (bat variants)
for only 14 (0.1%) of 14,582 rabid terrestrial animals
[35]. Thus, for this study, all exposures involving terres-
trial animals were attributed to the raccoon variant.
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In addition to a calculation of overall costs, statistics were
calculated by county and fiscal year. Correlation coeffi-
cients were calculated for PEP and specimen costs with
county population. A Pareto analysis was done for PEP
and specimen costs by species.
To determine whether PEP costs due to terrestrial rabies
are the same for patients exposed in the county of treat-
ment and those exposed outside the treatment county, the
average PEP cost was calculated and compared for the two
groups. The null hypothesis was that the average cost of
PEP was the same for both groups. This hypothesis was
tested using Students' t-test for comparison of means. For
this analysis we assumed the exposures are independent
events.
Data management and statistical analyses were conducted
using MS Access, MS Excel, and SAS. For graphics S-Plus,
MS Excel and MS PowerPoint were used.
Results
Overall costs
For the study counties, the total cost of prevention activi-
ties for both terrestrial and bat rabies during fiscal years
1999–2001 was $2,143,905. Of this total, $1,948,008
(90.9%) represented PEP costs, $100,278 (4.7%) repre-
sented specimen preparation/shipment costs, and
$95,618 (4.4%) represented pet vaccination clinic costs.
Table 1 presents the proportion of these expenses related
to raccoon rabies variant, by individual study county and
payer. Because vaccination clinic costs may be incurred
regardless of rabies variant, they are included in Table 1
but cannot be definitively attributed to the presence of
raccoon variant rabies.
The total expenses that may be attributed to terrestrial
rabies in this study were $784,529 (36.6%) for the three-
year period, if including all vaccination clinic costs. With-
out clinic costs, the total was $688,911 (32.1%) (Table 1).
By fiscal year the terrestrial rabies-associated expenses
(including clinic costs) were $247,700 in 1999–2000,
$261,805 in 2000–2001, and $277,140 in 2001–2002
(Table 2). The NYSDOH reimbursement system provided
funds to cover 52% of the total terrestrial rabies-associ-
ated costs ($406,428), about 34% was covered by third
party health insurers (for PEPs), about 8% was covered by
donations for vaccination clinics, and about 7% was cov-
ered by the LHDs.
The average per capita cost for terrestrial rabies including
PEPs, specimen preparation/shipment, and pet vaccina-
tion clinics was $0.32, with a range of $0.10 to $0.77.
PEP costs
PEP was administered to 2,085 persons in the five coun-
ties during the 1999–2002 fiscal years. Terrestrial animal
exposures were associated with 657 PEPs (32%). Terres-
trial rabies-associated PEP costs were $618,274 (32%)
(Table 1). Costs vary by fiscal year (Table 2), increasing
from $190,359 in 1999–2000 to $219,424 in 2001–2002.
The State reimbursed $307,470 (49.7%) of the terrestrial
rabies-associated costs, $263,240 (42.6%) was covered by
third party payers, and $47,564 (7.7%) was paid by LHDs
(Table 3). The average terrestrial rabies-associated PEP
cost was $941.06, with a range of $440.21 to $1,884.97
per county (Table 3).
Cats were associated with 43% (281) of the terrestrial
rabies PEPs, dogs with 27% (179), and raccoons with
16% (102) (Figure 1). Other species were reported for
14% of the PEPs, including skunk, fox, woodchuck, cattle,
ferret, coyote, beaver, squirrel, monkey, opossum, porcu-
pine, rabbit, tiger, and wolf. PEP costs associated with
dogs and cats were $437,225, 70.7% of the total terrestrial
rabies-associated PEP costs. The only county with an ORV
program had no PEP due to raccoon exposures. A Pareto
analysis of PEP costs by species indicates that about 86%
are due to incidents involving cats, dogs and raccoons,
and 70% of the PEPs were due to contacts with pets. Dur-
ing the study period, only three dogs were confirmed with
rabies and none in the study counties, compared to a total
of 18 cats (all confirmed to have raccoon variant).
Forty-three (6.5%) of the patients receiving PEP due to ter-
restrial rabies exposures were exposed in a county other
than the one providing the treatment and twenty-nine
(4.4%) were exposed outside the State or country. The
average PEP cost for patients exposed in the county pro-
viding the treatment was $959.25, compared to an aver-
age cost for patients exposed elsewhere of $793.19 (t =
2.08, df = 655, p = 0.0383). The association of this factor
(treatment within or outside exposure county) with com-
pletion of treatment was not assessed.
The average per capita cost for terrestrial rabies PEPs dur-
ing the three-year study period was $0.25, with a range of
$0.08 to $0.34. The county population size was highly
correlated with the number of PEPs (r = 0.86) and PEP
costs (r = 0.75), but not with PEP average cost (r = -0.21).
A cost < $300 was reported for 132 terrestrial rabies-asso-
ciated PEPs. LHDs reported these represented patients not
receiving a full five-dose vaccine series and immune glob-
ulin, PEP for lower weight children (because HRIG costs
are based on body weight), or incomplete submission of
bills. The reasons provided for not receiving a full treat-
ment series included repeat PEPs that only require two
doses of vaccine, stopping the PEP when the animal was
found not to be rabid, and stopping the PEP after it was
BMC Public Health 2007, 7:47 http://www.biomedcentral.com/1471-2458/7/47
Page 5 of 10
(page number not for citation purposes)
started by an emergency room, private doctor or health
center out of county after determining it was not needed.
Having the exposure and PEP in different counties was
also reported as a cause for incomplete submission of bills
to the LHD.
Specimen costs
During the study period, 4,393 specimens were submitted
for rabies testing from the study counties at a cost of
$95,618. About 46% (2,018) of the specimens were ter-
restrial animals, but these specimens accounted for 70%
of the submission costs ($70,637) (Table 1). The State
reimbursed 91.4% ($64,596) of the terrestrial animal
specimen submission costs.
The average cost of terrestrial animal specimen prepara-
tion/shipment was $35, with variation across counties
(Table 3). The total cost for 14 large animal (horse, cattle)
specimens was $278.34, at an average cost of $19.88. For
all other specimens, the total cost was $70,359.10, at an
average cost of $35. It is unexpected to find lower reported
costs for large animal specimens because LHDs are per-
mitted to voucher a larger amount for them. Because
horses and cattle are found normally on farms, prepara-
tion of the specimens may be assumed as part of the reg-
ular veterinary work and not reported as associated with
rabies testing.
Regarding species submitted for testing, cats comprised
36% (733); dogs 19% (392); raccoons 15% (305), and
skunks 11% (218) (Figure 2). Rodents, rabbits, opossum,
woodchuck, fox, and deer comprised < 4% each, with
other species making up < 3%. A Pareto analysis indicates
that about 82% of the terrestrial specimen expenditures
were for cats, raccoons, skunks, and dogs.
The average per capita cost for terrestrial rabies specimen
preparation/submission was $0.03 (range = $0.0003–
$0.05). The county population size was highly correlated
with the number of specimens (r = 0.80), specimen prep-
aration/shipment costs (r = 0.81), and the average speci-
men cost (r = 0.76).
LHD interviews indicated that veterinarians are contracted
for specimen preparation in three counties. One county
uses its own personnel. In two counties, veterinarians are
paid according to the species, whereas in a third county
veterinarians are paid a fixed fee per specimen. However,
the reimbursement vouchers for that county did not item-
ize the veterinarian fee and the vouchers reported varying
costs. In one county, veterinarians ship the specimens and
report the cost to the LHD. Two counties report no cost for
some shipments, usually for bats. Although shipment
costs vary based on specimen weight, one county calcu-
lates a fixed-cost per specimen for reimbursement pur-
poses. The formula is based on the average time to prepare
a specimen, staff salary for that time, and average shipping
costs.
Vaccination clinic costs
There were 26,185 animals vaccinated in study county-
sponsored clinics. The total cost was $95,618, of which
$34,362 (36%) was reimbursed by NYSDOH (Table 1),
$62,758 (66%) was from owner donations, and $614
(1%) was covered by LHDs. Little change was observed in
the annual clinic costs through the study period (Table 2).
Vaccination costs varied by county, from $1200 to
$44,764 (Table 2).
As reported by four counties, 57% of the vaccinated ani-
mals were dogs and 43% were cats. The average cost per
Table 1: Raccoon-variant rabies costs, fiscal years 1999–2000 to 2001–2002, in five selected counties of NYS (with percentage total cost 
across all variants attributable to raccoon rabies)
County A County B County C County D County E Total
$ % $ % $ % $ % $ % $ %
PEPs Total $89,801.05 39.99% $7,861.71 12.15% $58,547.63 48.39% $147,027.28 54.57% $315,036.04 24.84% $618,273.71 31.74%
State $53,303.38 41.65% $723.21 6.07% $23,723.80 47.12% $36,590.63 69.35% $193,128.73 27.84% $307,469.75 32.83%
County $5,735.18 32.99% $0.00 0.00% $7,327.49 59.32% $12,692.44 73.54% $21,808.87 32.83% $47,563.98 40.93%
Third party $30,762.49 38.85% $7,138.50 14.28% $27,496.34 47.16% $97,744.21 49.01% $100,098.44 19.70% $263,239.98 29.41%
Specimens Total $74.00 100.00% $1,631.95 75.94% $10,401.16 60.40% $10,734.02 62.80% $47,796.31 74.98% $70,637.44 70.44%
State $74.00 100.00% $1,579.25 75.61% $9,569.26 58.48% $10,734.02 62.80% $42,639.89 74.00% $64,596.42 69.28%
County $0.00 0.00% $52.70 87.22% $831.90 97.05% $0.00 0.00% $5,156.42 84.20% $6,041.02 85.79%
Vaccination Total $25,946.24 (N.A.) $20,470.83 (N.A.) $3,237.50 (N.A.) $44,763.60 (N.A.) $1,200.00 (N.A.) $95,618.17 (N.A.)
Clinics State $6,501.74 (N.A.) $9,832.54 (N.A.) $3,213.75 (N.A.) $13,614.08 (N.A.) $1,200.00 (N.A.) $34,362.11 (N.A.)
County $0.00 (N.A.) $0.00 (N.A.) $23.75 (N.A.) $589.78 (N.A.) $0.00 (N.A.) $613.53 (N.A.)
Donations* $19,685.00 (N.A.) $10,638.29 (N.A.) $0.00 (N.A.) $32,435.29 (N.A.) $0.00 (N.A.) $62,758.58 (N.A.)
*Donations for vaccination clinics. The excess in donations reported in counties A and D were not accounted for in the vaccination total cost. N.A.: Proportion attributable to 
raccoon variant is not applicable to vaccination clinic costs.
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Page 6 of 10
(page number not for citation purposes)
animal was $3.65, with variation from $0.33–$15.00 by
county. Lower values under vaccine purchase prices likely
indicate incomplete data. The average per capita cost for
pet vaccination clinics was $0.04 (range = $0.004–$0.53).
County population size was not correlated with the
number of animals vaccinated (r = -0.02), but was
inversely correlated with clinic total costs (r = -0.57) and
partially correlated with the average cost per animal vacci-
nated (r = 0.32).
Discussion
The cost summary presented in this pilot study is an initial
quantification of rabies reimbursement data in NYS for
PEPs, specimen preparation/shipment, and pet vaccina-
tion for five counties over a three-year time period. This
data may assist in determining the parameters for the
potential savings to be achieved if ORV or some other pre-
vention/control program is used to reduce or eliminate
the raccoon rabies virus variant in an eastern U.S. state.
This study found that terrestrial rabies accounts for more
than a third (37%) of the reimbursed rabies prevention
and control costs. The study found that in NYS, the State
bears the largest proportion of the reported costs. About
half of all expenses were covered by the State in the five
counties studied. The LHDs covered 7% of the total
expenses. While the amount spent by LHDs is a small pro-
portion of the total costs of terrestrial rabies control
reported in this study, for some counties this may repre-
sent an important impact to their budget.
The per-capita cost of terrestrial rabies including PEP,
specimen cost and pet vaccination clinics costs was esti-
mated to be $0.32. However, use of this average in esti-
mates of potential savings from ORV may considerably
over- or under-estimate the potential savings as indicated
by the county variation in average costs from $0.10–$0.77
per person. Although counties with larger population
sizes had greater PEP and specimen costs, the per capita
cost was highest in the smallest county, perhaps reflecting
economies of scale in larger counties able to prorate their
costs over a larger number of exposures. The fact that total
terrestrial variant-reimbursed costs are increasing despite
a relatively stable enzootic state of rabies in NYS, and
active prevention and control programs, should be con-
sidered when estimating the future savings potentially
associated with use of control programs.
PEP
PEP expenses account for about 90% of the overall costs
reported in this study. Thus, PEP is a large component of
possible cost savings to be produced by public health
intervention to control raccoon rabies. If ORV is used
effectively to eliminate the raccoon variant, raccoon
attacks are likely to be minimized and there will be no
Table 2: Terrestrial rabies costs by fiscal year and county
County 1999–2000 2000–2001 2001–2002 Total
Postexposure Prophylaxis
A $25,782.27 $48,655.38 $15,363.40 $89,801.05
B $2,122.21 $2,103.25 $3,636.25 $7,861.71
C $20,828.65 $13,441.87 $24,277.11 $58,547.63
D $59,738.40 $62,359.17 $24,929.71 $147,027.28
E $81,887.23 $81,931.73 $151,217.08 $315,036.04
All counties $190,358.76 $208,491.40 $219,423.55 $618,273.71
Specimen Submission
A $0.00 $74.00 $0.00 $74.00
B $411.00 $666.50 $554.45 $1,631.95
C $6,250.16 $1,516.96 $2,634.04 $10,401.16
D $4,310.68 $3,307.70 $3,115.64 $10,734.02
E $13,592.06 $15,450.43 $18,753.82 $47,796.31
All counties $24,563.90 $21,015.59 $25,057.95 $70,637.44
Vaccination Clinics
A $8,778.75 $9,552.84 $7,614.65 $25,946.24
B $6,101.45 $6,924.33 $7,445.05 $20,470.83
C $1,023.75 $1,153.75 $1,060.00 $3,237.50
D $15,046.67 $13,807.77 $15,909.16 $44,763.60
E $0.00 $570.00 $630.00 $1,200.00
All counties $30,950.62 $32,008.69 $32,658.86 $95,618.17
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spillover of rabies to other species from this variant, thus
reducing the total number of rabid animals and human
exposures. In this study about 16% of the PEPs attributed
to raccoon variant rabies were related directly to raccoon
incidents, and 4% were due to skunk incidents. With rac-
coons and skunks unlikely to attack people if not rabid, it
can be assumed that raccoon rabies elimination would
eliminate most of the PEPs related to these species. Expo-
sure to these two species represented 131 incidents for the
5 counties in the 3-year study period, at an estimated PEP
cost of $125,271 representing 16% of the total terrestrial-
associated costs.
Humans have more frequent contact with domesticated
species than with wildlife, and bites to humans from these
species frequently occur for reasons unrelated to rabies. In
this study bites from dogs and cats accounted for 70% of
the total terrestrial-associated PEP costs. Although elimi-
nation of the raccoon variant with ORV would reduce the
number of rabid pets and other domestic animals and
thus exposures to rabies, bites from pets will continue.
Thus elimination of raccoon variant would result in a
reduction in PEP costs associated with dog and cat inci-
dents, but the reduction may not be substantial because
most dog and cat bites are not due to the animal being
rabid. PEP costs associated with pet exposures will likely
not decline significantly until there is sufficient assurance
that the raccoon variant has truly been eliminated and the
probability of a pet being rabid is sufficiently low that PEP
is not warranted even when the pet's rabies status cannot
be verified. Changes in policies about providing PEP
when a pet's rabies status cannot be determined would
require a sufficient period without raccoon variant and
without it encroaching from neighboring areas. These
changes also assume no other terrestrial variants with fre-
quent spillover to pets. If the raccoon variant had been
eliminated from these five counties during the three-year
study period and there was sufficient confidence that ter-
restrial animal-related exposures did not require PEP con-
sideration, the maximum potential savings would have
been 657 PEPs avoided at an estimated cost savings of
$618,274.
Table 3: Terrestrial rabies costs by payer and county, NYS fiscal years 1999–2000 to 2001–2002
County Number of persons treated, specimens submitted, or 
animals vaccinated
State Cost Third Party Cost Donations County Cost Average Cost*
Post exposure prophylaxis
A 126 $53,303.38 $30,762.49 - $5,735.18 $712.71
B 7 $723.21 $7,138.50 - $0.00 $1,123.10
C 133 $23,723.80 $27,496.34 - $7,327.49 $440.21
D 78 $36,590.63 $97,744.21 - $12,692.44 $1,884.97
E 313 $193,128.73 $100,098.44 - $21,808.87 $1,006.50
All counties 657 $307,469.75 $263,239.98 - $47,563.98 $941.06
Specimen Submission
A 2 $74.00 - - $0.00 $37.00
B 114 $1,579.25 - - $52.70 $14.32
C 321 $9,569.26 - - $831.90 $32.40
D 503 $10,734.02 - - $0.00 $21.34
E 1078 $42,639.89 - - $5,156.42 $44.34
All counties 2,018 $64,596.42 - - $6,041.02 $35.00
Vaccine Clinics
A 4140 $6,501.74 - $19,685.00 $0.00 $6.27
B 3309 $9,832.54 - $10,638.29 $0.00 $6.19
C 9915 $3,213.75 - $0.00 $23.75 $0.33
D 8741 $13,614.08 - $32,435.29 $589.78 $5.12
E 80 $1,200.00 - $0.00 $0.00 $15.00
All counties 26,185 $34,362.11 - $62,758.58 $613.53 $3.65
All Categories
A - $59,879.12 $30,762.49 $19,685.00 $5,735.18 -
B - $12,135.00 $7,138.50 $10,638.29 $52.70 -
C - $36,506.81 $27,496.34 $0.00 $8,183.14 -
D - $60,938.73 $97,744.21 $32,435.29 $13,282.22 -
E - $236,968.62 $100,098.44 $0.00 $26,965.29 -
All counties - $406,428.28 $263,239.98 $62,758.58 $54,218.53 -
* Average cost = (cost/n)
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Animal specimens
With control of raccoon variant rabies, there should be
fewer wildlife specimens to submit. This study found that
70% of the specimens submitted for testing were for ter-
restrial species, primarily dogs, cats, raccoons and skunks.
If all raccoon and skunk submissions were eliminated by
eliminating raccoon variant rabies, the cost savings for the
study period would have been 26% of the total cost for
terrestrial rabies specimen preparation/shipment, repre-
senting a savings of 523 specimens that would not have
been prepared and shipped. This would yield an esti-
mated cost savings of $24,228, accounting for 3% of the
total terrestrial-associated costs.
Dog and cat specimens are submitted when the animal is
showing signs of rabies because neurologic animals must
be euthanized and tested after a bite to a human. Even
with elimination of the raccoon variant, there will be
occasional bites from neurologic pets due to bat rabies or
other diseases. However, specimen shipments are likely to
be considerably reduced. In NYS, avoiding 4,393 speci-
men shipments for all species at a cost savings of $95,618
is an upper limit of the potential savings in five counties
over a three-year period.
Vaccination clinics
NYS law requires rabies vaccination of pet dogs, cats and
ferrets. This requirement would not be modified in a sce-
nario where ORV controlled or eliminated raccoon rabies
because bat variants remain. The possibility of transloca-
tion or reintroduction of rabies in wildlife also remains,
therefore pets will continue being vaccinated.
An elimination of terrestrial rabies could lead to a recon-
sideration of the need for State resources to pay for pet
vaccination clinics. Thus, State-associated costs of
$34,362 could be considered a possible savings to be
achieved with ORV. However, if pet vaccination continues
as recommended by national guidelines and required by
state laws, total vaccination costs may potentially increase
if the costs associated with individual veterinarian vacci-
nations are higher than mass clinic costs. The current
study indicates a wide disparity in the per-animal cost of
rabies vaccination, ranging from $0.33 for a large county
that offers mass vaccination clinics to $15.00 for a large
county that reimburses a flat fee to veterinarians for vacci-
nating pets at their regular practice.
Conclusion
An initial pilot study of the reimbursements provided for
rabies costs in five NYS counties over a three-year period
indicates a wide variability in costs by county. Counties
with larger populations experienced larger PEP and speci-
men shipment/preparation costs. The study indicated that
there are wide variations in the ways that LHDs estimate
rabies-associated costs. Such potential variation must be
considered in developing estimates of possible ORV-
related cost savings. Within the limitations of LHD esti-
mations of cost data, this study offers specific cost data for
Species submitted for laboratory testing associated with ter-restrial ra ies incidents, five c un ies of NYS, fiscal years 1999–2000 to 2001–2002Figure 2
Species submitted for laboratory testing associated with ter-
restrial rabies incidents, five counties of NYS, fiscal years 
1999–2000 to 2001–2002.
Terrestrial species associated with PEPs, five counties of NYS, fisc years 1999–2000 to 2001–2002Figure 1
Terrestrial species associated with PEPs, five counties of 
NYS, fiscal years 1999–2000 to 2001–2002.
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two critical factors, PEPs and specimen preparation/ship-
ments, as well as the costs of pet vaccination. Actual data
such as that obtained in this pilot study are critical for bas-
ing the parameters chosen for economic modelling of
potential ORV benefit on realistic scenarios.
Limitations
Interviews with counties indicated that cost data is not
universally complete or accurate if based on estimates.
Year-specific costs may be affected by lags in reporting PEP
costs associated with insurance paperwork.
Overall averages for specimen preparation/shipment were
artificially lowered by the inclusion of a county with the
NYSDOH Rabies Laboratory which can hand deliver spec-
imens and thus incurs almost no specimen shipment
costs. The unexpected lower average cost for large animal
specimen preparation/shipment may also lead to an
underestimate of the average cost for all specimens. In one
county, species vaccinated was not reported, and in
another county, the reported cost per animal was below
the actual cost of vaccine and other supplies.
The five upstate New York counties may not be represent-
ative of other areas, although they represent almost a
quarter of the State's non-NYC population. With a larger
study, factors such as population density, health care
access, LHD capabilities, and animal rabies incidence
could be assessed for their impact on rabies-associated
costs. The influence of ORV itself could not be estimated
with only one ORV county in the study.
Assuming that these costs associated with raccoon rabies
would all be saved if ORV eliminated the raccoon variant
is only applicable to areas with no other terrestrial vari-
ants. With bats having an insignificant impact on rabies in
most other species (except humans), eliminating the rac-
coon variant could indeed result in elimination of most of
the costs associated with the current raccoon-variant out-
break. However, PEP costs are clearly the largest compo-
nent of the costs documented in this study. Until health
care and public health professionals are sufficiently confi-
dent of the low risk of rabies from terrestrial animal expo-
sures in areas where terrestrial variants have been
eliminated, PEPs will continue to occur in relation to
these exposures. With the evidence of raccoon variant in
skunks tracking similarly to the raccoon variant in rac-
coons [10], estimating that all of the costs associated with
raccoon variant could be eliminated with ORV for rac-
coons may also be inaccurate if skunks are now serving as
an alternative reservoir for this variant. Skunks do not
readily take the raccoon ORV bait nor are they as respon-
sive to immunization with V-RG.
The most significant limitation on potential PEP savings
from terrestrial variant control is the fact that in NYS only
31% of the PEPs were due to terrestrial animal exposures,
representing only 29% of the total PEP costs. There are
also many other rabies-associated costs that require better
data in order to appropriately model potential ORV-asso-
ciated savings, including costs associated with animal
confinements, quarantines, and euthanasias, personal
costs to those receiving PEP including time lost, pain and
suffering, and costs to governmental agencies for manag-
ing the rabies cases and the consequent consulting, inves-
tigation, and prevention/control measures.
Future research
The current study has demonstrated the feasibility of
obtaining actual cost data for several important rabies-
associated cost variables, and the variability in such costs
across time and geographic area. Additional studies are
required to include a larger area and additional important
cost variables. In the interim, the data from this pilot
study may be helpful in refining the parameters used in
any additional ORV cost-benefit analyses for the elimina-
tion or reduction of raccoon-variant rabies, including
modelling studies of animal to human transmission risks.
In these studies, it will be critical to include varying levels
of bait density and geographic size of baited areas, in addi-
tion to estimates of vaccine efficacy, as components of the
cost-benefit assessments.
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